# Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

> **NCT00186823** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 57 (actual)

## Conditions studied

- Leukemia, Acute Lymphocytic (ALL)
- Leukemia, Myeloid, Acute(AML)
- Leukemia, Myeloid, Chronic(CML)
- Juvenile Myelomonocytic Leukemia(JMML)
- Hemoglobinuria, Paroxysmal Nocturnal (PNH)
- Lymphoma, Non-Hodgkin (NHL)
- Myelodysplastic Syndrome (MDS)

## Interventions

- **DEVICE:** Miltenyi Biotec CliniMACS
- **PROCEDURE:** Stem Cell Transplantation
- **DRUG:** TBI, systemic chemotherapy and antibodies as follows:

## Key facts

- **NCT ID:** NCT00186823
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2005-09
- **Final completion:** 2009-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2009-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186823, "Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00186823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*